Teriparatide [RHPTH (1-34)] treatment reduces the incidence of back pain in postmenopausal women with osteoporosis

被引：0
|
作者：
Krege, JH
Xie, L
Genant, HK
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] UCSF, San Francisco, CA USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [31] Effects of intravenous zoledronic acid following subcutaneous teriparatide [(1-34)PTH] in postmenopausal osteoporosis
    Carlino, G.
    Cozzolongo, A.
    [J]. BONE, 2011, 48 : S220 - S220
  • [32] Early response of BMD and back pain to 6 months of teriparatide (RHPTH 1-34) in patients with and without prior antiresorptive treatment:: Interim results from the EUROFORS study
    Audran, M
    Eastell, R
    Minne, H
    Nicholson, T
    Boonen, S
    Avramidis, A
    Beardsworth, A
    Liu-Léage, S
    Ginis, A
    Nickelsen, T
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 93 - 93
  • [33] Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism
    Fuss, Carmina Teresa
    Burger-Stritt, Stephanie
    Horn, Silke
    Koschker, Ann-Cathrin
    Frey, Kathrin
    Meyer, Almuth
    Hahner, Stefanie
    [J]. ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2020, : 1 - 6
  • [34] Lack of bone neoplasms in cynomolgus macaques following long-term treatment with teriparatide [rhPTH(1-34)].
    Vahle, J. L.
    Francis, P. C.
    Westmore, M.
    Schmidt, A.
    Wang, J.
    Zuehlke, U.
    Sato, M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S187 - S187
  • [35] Teriparatide (biosynthetic human parathyroid hormone 1-34): A new paradigm in the treatment of osteoporosis
    Brixen, KT
    Christensen, PM
    Ejersted, C
    Langdahl, BL
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 94 (06) : 260 - 270
  • [36] Raloxifene improves the skeletal efficacy of teriparatide [RHPTH (1-34), TPTD] at clinically relevant doses
    Sato, M
    Schmidt, A
    Smith, S
    Ma, LY
    [J]. BONE, 2003, 32 (05) : S211 - S212
  • [37] Fracture incidence and changes in quality of life and back pain in women with osteoporosis treated with rhpth(I-34) (teriparatide):: 18 month results from the European Forsteo Observational Study (EFOS)
    Langdahl, B.
    Ljunggren, O.
    Lems, W.
    Walsh, B.
    Barker, C.
    Fahrleitner-Pammer, A.
    Karras, D.
    Rajzbaum, G.
    Jakob, F.
    Kutahov, A.
    Marin, F.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S158 - S158
  • [38] RALOXIFENE SKELETAL EFFECTS ARE IMPROVED WITH WEEKLY TERIPARATIDE [RHPTH (1-34)] IN OSTEOPENIC OVARIACTOMIZED RATS
    Ma, Y. L.
    Schmidt, A.
    Zeng, Q. Q.
    Zhang, Q.
    Jee, W. S.
    Sato, M.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S83 - S83
  • [39] Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose
    Vahle, JL
    Long, GG
    Sandusky, G
    Westmore, M
    Ma, YL
    Sato, M
    [J]. TOXICOLOGIC PATHOLOGY, 2004, 32 (04) : 426 - 438
  • [40] Teriparatide [human parathyroid hormone (1-34)] therapy in men with osteoporosis
    Kaufman, J. -M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S184 - S185
12345